Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.99.3 (
PRE
)
1,923
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proximal regulatory element B (PRE-B), located from positions -318 to -284 in the
alpha-myosin heavy chain
(MHC) promoter, stimulated expression from an otherwise weak
alpha-MHC
promoter fragment in primary rat neonatal cardiomyocytes but not in the C2C12 myogenic cell line.
PRE
-B interacted with
alpha-MHC
binding factor 2 (BF-2), a protein found in nuclear extracts from several neonatal rat tissues and cell types including cardiomyocytes. BF-2 DNA binding activity was greatly reduced in adult versus neonatal tissues. Methylation interference footprints indicated that BF-2 bound to an element that included an E-box consensus sequence. Site-directed mutations in the BF-2-binding site, that abolish BF-2 binding, reduced expression from the full-length
alpha-MHC
promoter by 70%. A BF-2-like protein interacts within the HF-1a element of the myosin light chain-2 (MLC-2) promoter suggesting that one of the proteins that regulates the
alpha-MHC
and MLC-2 genes is identical or closely related. Analysis of binding by competition gel shift experiments indicated that both BF-2 and HF-1a are E-box-binding proteins. The
alpha-MHC
and MLC-2 genes encode contractile proteins which are precursors of myosin. Regulation by the same transcription factor might indicate that the expression of
alpha-MHC
and MLC-2 is coordinately controlled.
...
PMID:Expression of the alpha-myosin heavy chain gene in the heart is regulated in part by an E-box-dependent mechanism. 842 36